| Typicality: | 0.436 |
| Saliency: | 0.435 |
| by inhibiting the production of thromboxane | 3 | manner |
| aspirin → be → antiplatelet drug | 4 |
| aspirin → have → antiplatelet effect | 4 |
| aspirin → be → antiplatelet agent | 4 |
| aspirin → be → antiplatelet | 3 |
| negative | neutral | positive |
| 0.148 | 0.703 | 0.149 |
| Raw frequency | 15 |
| Normalized frequency | 0.435 |
| Modifier score | 0.500 |
| Perplexity | 13.041 |